Eupraxia is a clinical-stage biotechnology company developing targeted therapies designed to deliver the right drug dose, in the right place, for the right amount of time.

SCIENCE, STRATEGY, AND A RELENTLESS FOCUS ON IMPACT

Many of today’s treatments require trade-offs in efficacy, safety, and convenience. Eupraxia’s founders started the company believing the norm in medical interventions isn’t good enough; people deserve better.

www.eupraxiapharma.com